RAPT Therapeutics RAPT
Last Price
52 Week Range
$5.67 - $57.86
Next Earnings Date
Mar 05 2026
Next Earnings Date
Mar 05 2026
Last Price
RAPT Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
RAPT Therapeutics, Inc. | 8-K | January 20, 2026 | |
RAPT Therapeutics, Inc. | 8-K | January 14, 2026 | |
RAPT Therapeutics, Inc. | 8-K | November 28, 2025 | |
RAPT Therapeutics, Inc. | 8-K | November 6, 2025 | |
RAPT Therapeutics, Inc. | 10-Q | November 6, 2025 | |
RAPT Therapeutics, Inc. | 8-K | October 23, 2025 | |
RAPT Therapeutics, Inc. | 8-K | August 7, 2025 | |
RAPT Therapeutics, Inc. | 10-Q | August 7, 2025 | |
RAPT Therapeutics, Inc. | 8-K | July 8, 2025 | |
RAPT Therapeutics, Inc. | 8-K | June 23, 2025 | |
RAPT Therapeutics, Inc. | 8-K | June 17, 2025 | |
RAPT Therapeutics, Inc. | 8-K | June 9, 2025 | |
RAPT Therapeutics, Inc. | 8-K | May 29, 2025 | |
RAPT Therapeutics, Inc. | 8-K | May 28, 2025 | |
RAPT Therapeutics, Inc. | 8-K | May 8, 2025 | |
RAPT Therapeutics, Inc. | 10-Q | May 8, 2025 | |
RAPT Therapeutics, Inc. | DEF 14A | April 14, 2025 | |
RAPT Therapeutics, Inc. | DEFA14A | April 14, 2025 | |
RAPT Therapeutics, Inc. | ARS | April 14, 2025 | |
RAPT Therapeutics, Inc. | PRE 14A | April 4, 2025 | |
RAPT Therapeutics, Inc. | 8-K | March 27, 2025 | |
RAPT Therapeutics, Inc. | 8-K | March 6, 2025 | |
RAPT Therapeutics, Inc. | 10-K | March 6, 2025 | |
RAPT Therapeutics, Inc. | 8-K | January 13, 2025 | |
RAPT Therapeutics, Inc. | 8-K | January 6, 2025 | |
RAPT Therapeutics, Inc. | 8-K | December 23, 2024 | |
RAPT Therapeutics, Inc. | 8-K | December 23, 2024 | |
RAPT Therapeutics, Inc. | 8-K | November 15, 2024 | |
RAPT Therapeutics, Inc. | 8-K | November 12, 2024 | |
RAPT Therapeutics, Inc. | 8-K | August 8, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.